Dr. Manuel Colucci, a researcher at the Molecular Oncology Lab of the Institute of Oncology Research (IOR), directed by Prof. Andrea Alimonti and member of SenoTarg, has been awarded the “Best Oral Presentation” at the “13th Research and Innovation Day in Human Medicine of Southern Switzerland,” held in Lugano on September 27, 2024. Dr. Colucci presented his study titled “Retinoic Acid Receptor Activation Reprograms Senescence Response and Enhances Anti-Tumor Activity of Natural Killer Cells,” which was published in Cancer Cell earlier this year.